RSS Feed
May 18th, 2012 
FAKE NEWS for the Zionist agenda Here are some of the latest health and medical news developments,
compiled by the editors of HealthDay:
Psychiatrist Apologizes for Study Supporting
Therapy to ‘Cure’ Gays
A man considered by some to be the father of modern psychiatry has
apologized for his 2001 study that supported the use of so-called
reparative therapy to “cure” gay people who were strongly motivated to
change their sexual orientation.
Dr. Robert L. Spitzer‘s apology appears in a short letter to be
published this month in Archives of Sexual Behavior, the journal
that published the original study, The New York Times reported.
“I believe I owe the gay community an apology,” his letter
concludes.
Reparative therapy, also called sexual reorientation or conversion
therapy is a theory promoted by social conservatives, who used Spitzer’s
study to push the idea that homosexuality is a choice and can be
cured.
That idea is rejected by psychiatric experts, and a World Health
Organization report calls the therapy “a serious threat to the health and
well-being — even the lives — of affected people,” The Times
reported.
—–
U.S. Panel Mulls Bioterrorism Protection for
Children
The question of whether the anthrax vaccine and other treatments being
stockpiled in case of a bioterror attack should be tested on children is
being considered by the Presidential Commission for the Study of
Bioethical Issues.
“We can’t just assume that what we have for adults works for children,”
Health and Human Services Secretary Kathleen Sebelius told the commission
Thursday, the Associated Press reported.
The panel began discussing the issue Thursday and its recommendations
are expected by the end of the year.
“There are serious ethical issues around the development of medical
countermeasures for children in general,” Sebelius said, the AP
reported.
While it is important to develop ways to protect children from
bioterror attacks, it must be done in a way that puts “our children’s
safety as our highest priority,” she noted.
—–
Stem Cell-Based Drug Approved in
Canada
The first manufactured drug based on stem cells has been approved by
Canadian regulators.
The drug Prochymal was approved to treat children suffering from
graft-versusu-host disease, a potentially deadly complication of bone
marrow transplantation. The drug is made by Osiris Therapeutics of
Columbia, Md., The New York Times reported.
The approval is seen as a boost for the field of regenerative
medicine.
“It’s really a good day for the concept and the hope behind stem cell
therapies becoming a reality,” C. Randal Mills, the chief executive of
Osiris, told The Times.
The company plans to apply later this year for U.S. Food and Drug
Administration approval of the drug.
—–
Consumers Should Avoid South Korean Shellfish:
FDA
U.S. federal and state officials are warning consumers against eating
shellfish from South Korea and say that retailers should stop selling
it.
A Food and Drug Administration analysis of the South Korean shellfish
program found unacceptable water pollution levels in shellfish-growing
areas and periodic presence of norovirus, which can cause gastroenteritis
(stomach flu), the Washington Post reported.
On May 1, the FDA removed firms that transports South Korean shellfish
off its list of approves shippers and said it may launch a recall of South
Korean shellfish, specifically fresh, frozen or processed oysters, clams,
mussels and scallops.
The FDA advisory does not affect South Korean crab or shrimp, or any
shellfish grown and produced in the U.S., the Post reported.
—–
Related posts:
Views: 0
Posted in 
Tags: 
